ATE348106T1 - Peptidanaloga abgeleitet vom tumornekrose-faktor- rezeptor - Google Patents
Peptidanaloga abgeleitet vom tumornekrose-faktor- rezeptorInfo
- Publication number
- ATE348106T1 ATE348106T1 AT98923839T AT98923839T ATE348106T1 AT E348106 T1 ATE348106 T1 AT E348106T1 AT 98923839 T AT98923839 T AT 98923839T AT 98923839 T AT98923839 T AT 98923839T AT E348106 T1 ATE348106 T1 AT E348106T1
- Authority
- AT
- Austria
- Prior art keywords
- necrosis factor
- tumor necrosis
- factor receptor
- tnf
- peptide analogs
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70578—NGF-receptor/TNF-receptor superfamily, e.g. CD27, CD30, CD40, CD95
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Gastroenterology & Hepatology (AREA)
- Toxicology (AREA)
- Immunology (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Zoology (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Cell Biology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/866,545 US6265535B1 (en) | 1997-05-30 | 1997-05-30 | Peptides and peptide analogues designed from binding sites of tumor necrosis factor receptor superfamily and their uses |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE348106T1 true ATE348106T1 (de) | 2007-01-15 |
Family
ID=25347839
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT98923839T ATE348106T1 (de) | 1997-05-30 | 1998-05-29 | Peptidanaloga abgeleitet vom tumornekrose-faktor- rezeptor |
Country Status (10)
Country | Link |
---|---|
US (1) | US6265535B1 (de) |
EP (2) | EP1837344A1 (de) |
AT (1) | ATE348106T1 (de) |
AU (4) | AU744925B2 (de) |
CA (1) | CA2291963C (de) |
DE (1) | DE69836638T2 (de) |
DK (1) | DK1011704T3 (de) |
ES (1) | ES2279575T3 (de) |
PT (1) | PT1011704E (de) |
WO (1) | WO1998053842A1 (de) |
Families Citing this family (31)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19948867A1 (de) * | 1998-10-09 | 2000-08-17 | Bioserv Ag | TNFalpha bindende Peptide und ihre Anwendung für Detektion, Inaktivierung und/oder Entfernung von TNFalpha aus biologischen Flüssigkeiten |
ES2388341T3 (es) | 1998-10-23 | 2012-10-11 | Kirin-Amgen Inc. | Péptidos miméticos de trombopoyetina diméricos que se unen al receptor MPL y que tienen actividad trombopoyética |
US6660843B1 (en) | 1998-10-23 | 2003-12-09 | Amgen Inc. | Modified peptides as therapeutic agents |
US7488590B2 (en) | 1998-10-23 | 2009-02-10 | Amgen Inc. | Modified peptides as therapeutic agents |
IL130989A0 (en) | 1999-07-20 | 2001-01-28 | Compugen Ltd | Variants of alternative splicing |
AU777634B2 (en) * | 1999-07-28 | 2004-10-28 | Kazuhiro Aoki | Methods of inhibiting osteoclastogenesis |
US6673771B1 (en) * | 1999-07-28 | 2004-01-06 | The Trustees Of The University Of Pennsylvania | Methods of inhibiting osteoclast activity |
US6682739B1 (en) * | 1999-07-28 | 2004-01-27 | The Trustees Of The University Of Pennsylvania | Methods of inhibiting osteoclastogenesis |
US6808902B1 (en) | 1999-11-12 | 2004-10-26 | Amgen Inc. | Process for correction of a disulfide misfold in IL-1Ra Fc fusion molecules |
JP5048201B2 (ja) | 2000-08-04 | 2012-10-17 | ディーエムアイ バイオサイエンシズ インコーポレイテッド | ジケトピペラジン類の使用方法とジケトピペラジン類を含む組成物 |
DE60235989D1 (de) | 2001-06-26 | 2010-05-27 | Amgen Fremont Inc | Antikörper gegen opgl |
CA2490542C (en) | 2002-05-23 | 2013-07-16 | Mark I. Greene | Fas peptide mimetics and uses thereof |
JP2006504406A (ja) | 2002-06-28 | 2006-02-09 | セントカー・インコーポレーテツド | 哺乳動物のch1欠失ミメティボディ、組成物、方法および使用 |
JP4674317B2 (ja) * | 2002-10-02 | 2011-04-20 | ディエムアイ アクイジション コーポレイション | 疾病の判定および監視 |
EP2517721A3 (de) | 2003-05-15 | 2013-04-10 | DMI Biosciences, Inc. | Behandlung von T-Zell-vermittelten Krankheiten |
WO2005066218A1 (en) * | 2003-12-30 | 2005-07-21 | 3M Innovative Properties Company | Fluoropolymer coagulation method and composition |
JP2008505928A (ja) | 2004-07-08 | 2008-02-28 | アムジェン インコーポレーテッド | 治療用ペプチド |
US8008453B2 (en) | 2005-08-12 | 2011-08-30 | Amgen Inc. | Modified Fc molecules |
US9283260B2 (en) | 2006-04-21 | 2016-03-15 | Amgen Inc. | Lyophilized therapeutic peptibody formulations |
US8217047B2 (en) * | 2008-05-27 | 2012-07-10 | Dmi Acquisition Corp. | Therapeutic methods and compounds |
JP2013512674A (ja) * | 2009-12-02 | 2013-04-18 | アクセルロン ファーマ, インコーポレイテッド | Fc融合タンパク質の血清半減期を増加させるための組成物および方法 |
EP2613786A4 (de) | 2010-09-07 | 2013-10-23 | Dmi Acquisition Corp | Behandlung von erkrankungen |
CN103415530A (zh) * | 2011-03-09 | 2013-11-27 | Jitsubo株式会社 | 新型的含有非肽性交联结构的交联肽、以及该交联肽的合成方法和用于该方法的新型有机化合物 |
EP2718328A4 (de) | 2011-06-08 | 2014-12-24 | Acceleron Pharma Inc | Zusammensetzungen und verfahren zur erhöhung der halbwertszeit von serum |
MX2014003856A (es) | 2011-10-10 | 2015-01-16 | Ampio Pharmaceuticals Inc | Dispositivos medicos implantables con tolerancia inmune incrementada y metodos para hacerlos e implantarlos. |
EP3721884A1 (de) | 2011-10-10 | 2020-10-14 | Ampio Pharmaceuticals, Inc. | Behandlung degenerativer gelenkerkrankung mit da-dkp (= aspartly-alanyl-diketopiperazin) |
EP2771007B1 (de) | 2011-10-28 | 2018-04-04 | Ampio Pharmaceuticals, Inc. | Behandlung von rhinitis |
US9808454B2 (en) | 2013-03-15 | 2017-11-07 | Ampio Pharmaceuticals, Inc. | Compositions for the mobilization, homing, expansion and differentiation of stem cells and methods of using the same |
US9365615B2 (en) | 2013-09-09 | 2016-06-14 | Jitsubo Co., Ltd. | Cross-linked peptides containing non-peptide cross-linked structure, method for synthesizing cross-linked peptides, and novel organic compound used in method |
KR20170045274A (ko) | 2014-08-18 | 2017-04-26 | 앰피오 파마슈티컬스 인코퍼레이티드 | 관절 징후의 치료 |
WO2016209969A1 (en) | 2015-06-22 | 2016-12-29 | Ampio Pharmaceuticals, Inc. | Use of low molecular weight fractions of human serum albumin in treating diseases |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NO812612L (no) | 1980-08-06 | 1982-02-08 | Ferring Pharma Ltd | Enzym-inhibitorer. |
GB9402331D0 (en) * | 1994-02-07 | 1994-03-30 | Univ Mcgill | Nerve growth factor structural analogs and their uses |
-
1997
- 1997-05-30 US US08/866,545 patent/US6265535B1/en not_active Expired - Lifetime
-
1998
- 1998-05-29 EP EP06025661A patent/EP1837344A1/de not_active Withdrawn
- 1998-05-29 EP EP98923839A patent/EP1011704B1/de not_active Expired - Lifetime
- 1998-05-29 DK DK98923839T patent/DK1011704T3/da active
- 1998-05-29 AT AT98923839T patent/ATE348106T1/de not_active IP Right Cessation
- 1998-05-29 DE DE69836638T patent/DE69836638T2/de not_active Expired - Lifetime
- 1998-05-29 CA CA2291963A patent/CA2291963C/en not_active Expired - Lifetime
- 1998-05-29 AU AU76036/98A patent/AU744925B2/en not_active Expired
- 1998-05-29 PT PT98923839T patent/PT1011704E/pt unknown
- 1998-05-29 WO PCT/US1998/010891 patent/WO1998053842A1/en active IP Right Grant
- 1998-05-29 ES ES98923839T patent/ES2279575T3/es not_active Expired - Lifetime
-
2002
- 2002-06-06 AU AU45844/02A patent/AU778124B2/en not_active Ceased
-
2005
- 2005-02-11 AU AU2005200634A patent/AU2005200634A1/en not_active Abandoned
-
2008
- 2008-11-13 AU AU2008243270A patent/AU2008243270B2/en not_active Expired
Also Published As
Publication number | Publication date |
---|---|
EP1837344A1 (de) | 2007-09-26 |
PT1011704E (pt) | 2007-03-30 |
DE69836638T2 (de) | 2007-10-04 |
AU4584402A (en) | 2002-07-25 |
AU744925B2 (en) | 2002-03-07 |
EP1011704B1 (de) | 2006-12-13 |
EP1011704A1 (de) | 2000-06-28 |
CA2291963C (en) | 2011-04-19 |
EP1011704A4 (de) | 2002-07-31 |
CA2291963A1 (en) | 1998-12-03 |
WO1998053842A1 (en) | 1998-12-03 |
AU2008243270B2 (en) | 2011-09-01 |
AU7603698A (en) | 1998-12-30 |
AU2005200634A1 (en) | 2005-03-17 |
AU778124B2 (en) | 2004-11-18 |
ES2279575T3 (es) | 2007-08-16 |
US6265535B1 (en) | 2001-07-24 |
DE69836638D1 (de) | 2007-01-25 |
AU2008243270A1 (en) | 2008-12-11 |
DK1011704T3 (da) | 2007-04-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE348106T1 (de) | Peptidanaloga abgeleitet vom tumornekrose-faktor- rezeptor | |
BR9812096A (pt) | Proteìna receptora/ligante solúvel interleucina-6 quimérica, seus análogos e seus usos | |
ATE168415T1 (de) | Wasserlösliche peptidanaloguen mit bindungstellen | |
DE60030450D1 (de) | Von MUC-1 abgeleitete Peptide | |
WO2003070747A3 (en) | Insulin and igf-1 receptor agonists and antagonists | |
LV12639B (lv) | Bifenilsulfonamidi ka duali angiotenzina un endotelina receptoru antagonisti | |
EP1009804A4 (de) | Für den capsaicin rezeptor kodierende nukleinsäuresequenzen und dem capsaicin rezeptor ähnliche polypeptide und ihre verwendung | |
WO2002002627A3 (en) | Interferon-like protein zcyto21 | |
DE60335216D1 (de) | Adiponektin-rezeptor und dafür kodierendes gen | |
CA2530027A1 (en) | Novel melanocortin receptor templates, peptides, and use thereof | |
ATE278778T1 (de) | Stabilisierende peptide, und polypeptide und antikörper die diese beinhalten | |
DE69715181T2 (de) | Peptid der löslichen form von acetylcholinesterase mit aktivität als calciumkanalmodulator | |
DK258789D0 (da) | Peptider, der blokerer bindingen af hiv-1 til cd4 receptorproteinet | |
ES2129120T3 (es) | Un receptor de celulas t humanas de la familia de receptores acoplados a la proteina g. | |
DE69429082T2 (de) | Knochenwachstumsfördernder faktor | |
MX9203175A (es) | Composicion de implante que contiene un peptido, polipeptido o proteina biologicamente activa y procedimiento para su preparacion. | |
DE69328060D1 (de) | Angiotensin-II Typ-1 Rezeptor und dessen Herstellung | |
DE69925116D1 (de) | Neue, physiologisch aktive peptide und ihre verwendung. | |
DE60109412D1 (en) | Therapeutische peptide | |
ATE283279T1 (de) | Therapeutische inhaltsstoffe | |
Cody et al. | Modifications of the C-Terminal Dipeptide of Angiotensin II Yielded a Novel Series of Analogues with Type II (AT~ 2) Receptor Selectivity | |
DE69032096T2 (de) | Antikörper gegen das carboxy-terminale Peptid des Somatotropin-Bindungsproteins der Ratte | |
AU4956901A (en) | Novel human 7tm proteins and polynucleotides encoding the same | |
WO1999027097A3 (en) | CLONING OF A TETRODOTOXIN-RESISTANT SODIUM CHANNEL α-SUBUNIT | |
EA200400384A1 (ru) | Растворимый рецептор т-клетки |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification |
Ref document number: 1011704 Country of ref document: EP |
|
REN | Ceased due to non-payment of the annual fee |